news
GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
13 June 2011 | By GlaxoSmithKline
GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced that the FDA has approved Potiga™ (ezogabine) Tablets...
List view / Grid view
Food and Drug Administration (FDA)
news
Abbott completes submission of new molecular test
23 May 2011 | By Abbott
Abbott announced it filed premarket approval applications for a new molecular diagnostic test...
news
Abbott statement on the FDA Advisory Committee recommendations on fenofibric acid
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
news
Abbott Receives FDA Approval for Molecular Test for Hepatitis C
18 May 2011 | By Abbott
Abbott has received approval from the FDA to market its RealTime PCR test for measuring the viral load of hepatitis C...
news
FDA approves Merck’s VICTRELIS™ (boceprevir) oral hepatitis C virus (HCV) protease inhibitor
13 May 2011 | By Merck
VICTRELIS is approved for the treatment of CHC genotype 1 infection...
news
FDA licenses Sanofi Pasteur’s new influenza vaccine delivered by intradermal microinjection
10 May 2011 | By Sanofi Pasteur
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal...
news
Abbott receives FDA approval to expand use of the RX ACCULINK® Carotid Stent System
6 May 2011 | By Abbott
Abbott announced that the FDA approved the RX ACCULINK® Carotid Stent System...
news
Novartis gains FDA approval for Afinitor®
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
news
FDA approves linagliptin tablets for the treatment of type 2 diabetes
3 May 2011 | By OgilvyHealthPR
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy…
news
FDA approves GSK’s Lamictal®XR™ (lamotrigine)
27 April 2011 | By GlaxoSmithKline
The FDA has approved Lamictal® XR™ (lamotrigine) Extended-Release Tablets for conversion to monotherapy...
news
Sanofi Pasteur announces FDA approval of Menactra®
22 April 2011 | By Sanofi Pasteur
Sanofi Pasteur announces that the FDA has granted licensure to expand the indication for its meningococcal conjugate vaccine...
news
Gilead and MicroDose Therapeutx announce license and collaboration agreement to develop MDT-637
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
news
FDA approves Roche’s HPV test for identifying women at highest risk for cervical cancer
20 April 2011 | By Roche
Roche announced that the FDA has approved the cobas HPV (Human Papillomavirus) Test...
news
FDA approves Rituxan plus a steroid for use in severe forms of vasculitis
19 April 2011 | By Biogen Idec
Genentech, and Biogen Idec announced today that the FDA approved Rituxan® (rituximab)...
news
Novartis drug Afinitor® recommended by FDA oncology advisory committee
12 April 2011 | By Novartis
Novartis announced that the FDA Oncologic Drugs Advisory Committee recommended approval of Afinitor® (everolimus) tablets...
